PLTR
Palantir
-- 69.910 SMCI
Super Micro Computer
-- 40.880 NVDA
NVIDIA
-- 140.790 TSLA
Tesla
-- 351.861 INTC
Intel
-- 22.170 
NEWS
Ensysce Biosciences Announces 1-for-15 Reverse Stock Split
Tuesday, 3rd December at 4:15 pm
SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Ensysce Biosciences, Inc. (NASDAQ: ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on Friday, December 6, 2024, effective at 12:01 a.m. Eastern Time, it will implement a 1-for-15 reverse split of its common stock. The Company's common stock will begin trading on a split-adjusted basis when the market opens on December 6, 2024, under its current trading symbol "ENSC". The new CUSIP number of the Company's common stock following the reverse stock split will be 293602 504.
The reverse stock split is intended, among other things, primarily to increase the bid price of the Company's common stock to enable the Company to regain compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market.
Tuesday, 3rd December at 4:15 pm
SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Ensysce Biosciences, Inc. (NASDAQ: ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on Friday, December 6, 2024, effective at 12:01 a.m. Eastern Time, it will implement a 1-for-15 reverse split of its common stock. The Company's common stock will begin trading on a split-adjusted basis when the market opens on December 6, 2024, under its current trading symbol "ENSC". The new CUSIP number of the Company's common stock following the reverse stock split will be 293602 504.
The reverse stock split is intended, among other things, primarily to increase the bid price of the Company's common stock to enable the Company to regain compliance with the minimum bid price requirement of $1.00 per share for continued listing on The Nasdaq Capital Market.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Thomas sago : is this a good new or bad new
Jaguar8 OP Thomas sago : It’s good for the company to comply with listing requirement
Thomas sago Jaguar8 OP : so if my share is 1 lot after reverse stock split will it be leaser
Jaguar8 OP Thomas sago : So for every 15 shares you have it will become 1 but don’t worry because the value doesn’t change because the price gets multiplied by 15. Caution though that almost always stock price plummets immediately post RS
Thomas sago Jaguar8 OP : oh ok